BioWorld

May 14, 1992

View Archived Issues

SERAGEN PLANS MORE FUSION TOXIN TRIALS

Read More

THERATECH BRAVES THE IPO MARKET

Read More

SYNERGEN-SYNTEX BEGINS ALS TRIALS

Read More

$180 MILLION SCIOS-NOVA MERGER DEAL

Read More

DIFFERENT INTERPRETATIONS OF IMNR RESULTS

Read More

CHUGAI DEAL PROPELS AMGEN

Read More

TRYOUT FOR EMBREX EGG INOCULATOR

Read More

PATENT TO COVER CURATIVE TECH PRODUCTS

Read More